$6.27 Million is the total value of Elefante Mark B's 77 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 42.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CVS | Buy | CVS HEALTH | $572,000 | +65.3% | 5,510 | +55.6% | 9.13% | -1.8% |
FISV | Buy | FISERV | $529,000 | +61.8% | 5,160 | +44.1% | 8.44% | -3.9% |
JNJ | Buy | JOHNSON & JOHNSON | $383,000 | +57.6% | 3,535 | +49.5% | 6.11% | -6.4% |
MA | Buy | MASTERCARD | $375,000 | +19.8% | 3,970 | +23.3% | 5.99% | -28.8% |
AAPL | Buy | APPLE INC | $373,000 | +25.2% | 3,422 | +20.6% | 5.96% | -25.6% |
PG | Buy | PROCTER & GAMBLE | $353,000 | +34.2% | 4,295 | +30.2% | 5.64% | -20.3% |
ADP | Buy | AUTOMATIC DATA PROCESSING | $339,000 | +39.5% | 3,780 | +31.2% | 5.41% | -17.1% |
MMM | New | 3M | $329,000 | – | 1,975 | +100.0% | 5.25% | – |
ATR | Buy | APTARGROUP | $324,000 | +44.0% | 4,135 | +33.4% | 5.17% | -14.5% |
NSRGY | Buy | NESTLE SA ADR | $315,000 | +6.4% | 4,230 | +6.3% | 5.03% | -36.8% |
UTX | Buy | UNITED TECHNOLOGIES | $286,000 | +23.3% | 2,850 | +18.3% | 4.57% | -26.8% |
GOOGL | Buy | ALPHABET INC CL A | $270,000 | 0.0% | 355 | +2.3% | 4.31% | -40.6% |
NVS | Buy | NOVARTIS AG ADR | $259,000 | +6.6% | 3,590 | +27.5% | 4.14% | -36.7% |
ROK | Sell | ROCKWELL AUTOMATION | $235,000 | +10.8% | 2,065 | -0.5% | 3.75% | -34.1% |
CB | New | CHUBB LIMITED | $229,000 | – | 1,923 | +100.0% | 3.66% | – |
PEP | New | PEPSICO | $229,000 | – | 2,232 | +100.0% | 3.66% | – |
XOM | New | EXXON MOBIL | $227,000 | – | 2,712 | +100.0% | 3.62% | – |
SLB | New | SCHLUMBERGER | $226,000 | – | 3,070 | +100.0% | 3.61% | – |
ABT | Buy | ABBOTT LABS | $208,000 | -1.0% | 4,965 | +5.9% | 3.32% | -41.2% |
ORCL | New | ORACLE | $203,000 | – | 4,955 | +100.0% | 3.24% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FISERV | 19 | Q2 2020 | 8.8% |
MASTERCARD | 19 | Q2 2020 | 8.4% |
APPLE INC | 19 | Q2 2020 | 8.0% |
ALPHABET INC CL A | 19 | Q2 2020 | 7.3% |
JOHNSON & JOHNSON | 19 | Q2 2020 | 6.5% |
PROCTER & GAMBLE | 19 | Q2 2020 | 7.1% |
AUTOMATIC DATA PROCESSING | 19 | Q2 2020 | 6.5% |
ABBOTT LABS | 19 | Q2 2020 | 5.6% |
NESTLE SA ADR | 19 | Q2 2020 | 8.0% |
NOVARTIS AG ADR | 19 | Q2 2020 | 6.5% |
View Elefante Mark B's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-07-28 |
13F-HR | 2020-05-07 |
13F-HR | 2020-01-15 |
13F-HR | 2019-11-06 |
13F-HR | 2019-07-24 |
13F-HR | 2019-05-02 |
13F-HR | 2019-01-24 |
13F-HR | 2018-10-15 |
13F-HR | 2018-07-30 |
13F-HR | 2018-04-24 |
View Elefante Mark B's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.